Skip to main content

Table 7 Clinical characteristics according to the occurrence of UTI and pyuria type

From: Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease

  

No UTI (N=223)

Overt UTI (N=33)

Pvalue†

  

Group AUTI- (N=151)

Group BUTI- (N=72)

  

Age*

 

47.8 ±13.5

47.2 ± 11.3

51.2 ± 11.8

NS

Female

number (%)

63 (41.7)

39 (54.2)

21 (63.6)

0.04

F/U Duration

Months

51.0 ± 40.3

86.2 ± 37.5

83.1 ± 43.3

<0.001

HTN (initial)

number (%)

90 (59.6)

51 (70.8)

26 (78.8)

NS

Stone (initial)

number (%)

22 (14.6)

12 (16.7)

6 (18.2)

NS

Initial eGFR‡

ml/min/1.73m2

93.4 ± 26.7

89.2 ± 33.0

84.7 ± 30.8

NS

Final eGFR‡

ml/min/1.73m2

87.6 ± 30.1

64.9 ± 38.1

57.6 ± 35.2

<0.001

ΔeGFR‡

ml/min/1.73m2/year

-0.9 ± 5.7

-2.6 ± 4.4

-3.6 ± 5.6

0.009

ESRD

number (%)

5 (3.3)

11 (15.3)

6 (18.2)

0.001

  1. Group AUTI- and BUTI- were classified as patients in group A and group B without overt UTI. *mean ± standard deviation (SD).
  2. † P value calculated using the One-Way ANOVA. Post-hoc analyses were performed using the Scheffe’s method.
  3. ‡ Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI equation (ml/min/1.73m2).
  4. ΔeGFR, annual reduction rate of estimated glomerular filtration rate; eGFR, estimated glomerular filtration rate; ESRD, end stage renal disease; F/U, follow-up; HTN, hypertension; UTI, urinary tract infection.